UA110880C2 - Заміщені амідином бета-лактами, їх одержання та застосування як антибактеріальних засобів - Google Patents

Заміщені амідином бета-лактами, їх одержання та застосування як антибактеріальних засобів

Info

Publication number
UA110880C2
UA110880C2 UAA201409319A UAA201409319A UA110880C2 UA 110880 C2 UA110880 C2 UA 110880C2 UA A201409319 A UAA201409319 A UA A201409319A UA A201409319 A UAA201409319 A UA A201409319A UA 110880 C2 UA110880 C2 UA 110880C2
Authority
UA
Ukraine
Prior art keywords
lacto
antibacterials
nose
beta
production
Prior art date
Application number
UAA201409319A
Other languages
English (en)
Inventor
Буркхард Кленке
Іріт Віганд
Гуідо Шіффер
Хайке Брьоц-Естерхельт
Самарендра Н. Маіті
Ехангір Хан
Андхе Редді
Чжісян Ян
Мустафа Хена
Гофен Цзя
Оу Лігун
Хун ЛЯН
Джуді Іп
Чуанжун Гао
Сабіха Таджаммул
Рахім Мухаммад
Гангулі Бісваджит
Original Assignee
Айкуріс Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Айкуріс Гмбх & Ко. Кг filed Critical Айкуріс Гмбх & Ко. Кг
Publication of UA110880C2 publication Critical patent/UA110880C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

У заявці описано нові β-лактами формули (І), їх одержання і застосування. Зокрема, у заявці описано нові β-лактами, що є заміщеними амідином похідними монобактаму, які застосовуються як протимікробні засоби, та їх одержання.(I)
UAA201409319A 2012-01-24 2013-01-23 Заміщені амідином бета-лактами, їх одержання та застосування як антибактеріальних засобів UA110880C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12152279 2012-01-24
PCT/EP2013/051217 WO2013110643A1 (en) 2012-01-24 2013-01-23 Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents

Publications (1)

Publication Number Publication Date
UA110880C2 true UA110880C2 (uk) 2016-02-25

Family

ID=47603723

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201409319A UA110880C2 (uk) 2012-01-24 2013-01-23 Заміщені амідином бета-лактами, їх одержання та застосування як антибактеріальних засобів

Country Status (43)

Country Link
US (2) US9556165B2 (uk)
EP (1) EP2806873B1 (uk)
JP (1) JP5869701B2 (uk)
KR (1) KR102036393B1 (uk)
CN (1) CN104203237A (uk)
AP (1) AP2014007880A0 (uk)
AR (1) AR089796A1 (uk)
AU (1) AU2013211575B2 (uk)
BR (1) BR112014017968A8 (uk)
CA (1) CA2862338C (uk)
CL (1) CL2014001956A1 (uk)
CO (1) CO7101240A2 (uk)
CU (1) CU24273B1 (uk)
CY (1) CY1117955T1 (uk)
DK (1) DK2806873T3 (uk)
EA (1) EA027126B1 (uk)
EC (1) ECSP14010249A (uk)
ES (1) ES2592403T3 (uk)
HK (1) HK1203389A1 (uk)
HR (1) HRP20161171T1 (uk)
HU (1) HUE030452T2 (uk)
IL (1) IL233805A (uk)
IN (1) IN2014MN01640A (uk)
LT (1) LT2806873T (uk)
MA (1) MA35905B1 (uk)
ME (1) ME02532B (uk)
MX (1) MX346602B (uk)
MY (1) MY173843A (uk)
NZ (1) NZ626951A (uk)
PE (1) PE20142345A1 (uk)
PH (1) PH12014501671A1 (uk)
PL (1) PL2806873T3 (uk)
PT (1) PT2806873T (uk)
RS (1) RS55210B1 (uk)
SG (1) SG11201403930XA (uk)
SI (1) SI2806873T1 (uk)
SM (1) SMT201600354B (uk)
TN (1) TN2014000297A1 (uk)
TW (1) TWI659953B (uk)
UA (1) UA110880C2 (uk)
UY (1) UY34585A (uk)
WO (1) WO2013110643A1 (uk)
ZA (1) ZA201405057B (uk)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015103583A1 (en) * 2014-01-06 2015-07-09 President And Fellows Of Harvard College Monobactams and methods of their synthesis and use
PE20161371A1 (es) 2014-03-24 2016-12-21 Novartis Ag Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas
CN105175335B (zh) * 2015-08-13 2017-11-03 南阳师范学院 一种3‑(3,3‑二氯烯丙氧基)‑1‑甲基吡唑‑5‑甲酰胺衍生物及其制备方法
CN108137573B (zh) * 2015-09-23 2021-06-11 诺华股份有限公司 单环内酰胺抗生素的盐和固体形式
RU2746129C2 (ru) * 2015-12-15 2021-04-07 Мерк Шарп И Доум Корп. Биарильные монобактамные соединения и способы их применения для лечения бактериальных инфекций
AU2017228870B2 (en) * 2016-03-07 2021-02-18 Merck Sharp & Dohme Llc Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
CN107641119B (zh) 2016-07-21 2019-11-08 中国科学院上海药物研究所 单环β-内酰胺-铁载体轭合物及其制备方法和用途
IL264686B1 (en) * 2016-08-26 2024-03-01 Codexis Inc Engineered imine reductases and methods for reversible amination of ketone and amine compounds
CA3043979A1 (en) 2016-11-18 2018-05-24 Aicuris Anti-Infective Cures Gmbh Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and acidifying agents, their preparation and use as antimicrobial pharmaceutical compositions
WO2018091671A1 (en) 2016-11-18 2018-05-24 Aicuris Anti-Infective Cures Gmbh Liposomal formulations of amidine substituted beta-lactam compounds for use in the treatment of bacterial infections
EP3558987A1 (en) 2016-12-21 2019-10-30 AiCuris GmbH & Co. KG COMBINATION THERAPY WITH AMIDINE SUBSTITUTED ß-LACTAM COMPOUNDS AND ß-LACTAMASE INHIBITORS FOR INFECTIONS WITH ANTIBIOTIC RESISTANT BACTERIAL STRAINS
JP2020527562A (ja) 2017-07-18 2020-09-10 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 置換３−ヘテロアリールオキシ−１ｈ−ピラゾール類及びそれらの塩、並びに、それらの除草活性物質としての使用
UY37824A (es) 2017-07-28 2019-02-28 Aicuris Anti Infective Cures Gmbh Forma cristalina de ácido (2s)-2-[[(z)-[1-(2-amino-4-tiazolil)-2-[[(3s)-2,2-dimetil-4-oxo-1-(sulfoxi)-3-azetidinil]amino]-2-oxoetiliden]amino]oxi]-3-[4-[imino[(3r)-3-piperidinilamino]metil]fenoxi]-propanoico
AU2018311521B2 (en) 2017-08-02 2022-03-03 Novartis Ag Process for preparing 1 -(((Z)-(1 -(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-y l)methyl)-1 -sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid
SG11202002575UA (en) * 2017-10-02 2020-04-29 Merck Sharp & Dohme Chromane monobactam compounds for the treatment of bacterial infections
SG11202002300QA (en) * 2017-10-02 2020-04-29 Arixa Pharmaceuticals Inc Aztreonam derivatives and uses thereof
CN111511737B (zh) * 2018-01-29 2022-10-18 南京明德新药研发有限公司 用于治疗细菌感染的单环β-内酰胺化合物
TW202024068A (zh) * 2018-11-13 2020-07-01 大陸商南京聖和藥業股份有限公司 單環內醯胺化合物及其應用
EP3901150A4 (en) 2018-12-18 2022-09-07 Medshine Discovery Inc. APPLICATION OF A MONOCYCLIC BETA-LACTAM COMPOUND IN PHARMACY
CN111303144B (zh) * 2019-12-13 2020-11-27 苏州信诺维医药科技有限公司 一种治疗细菌感染的化合物
WO2021121387A1 (zh) 2019-12-19 2021-06-24 南京明德新药研发有限公司 化合物在制药中的应用
CN111253405B (zh) * 2020-03-20 2022-12-16 南京安伦化工科技有限公司 一种比阿培南中间体的制备方法
CN111592536B (zh) * 2020-06-04 2023-11-03 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺化合物及其制备方法和应用
CN111675641B (zh) * 2020-06-04 2023-09-08 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺类化合物、单环内酰胺类化合物盐及其制备方法
EP4165039A4 (en) * 2020-07-16 2023-06-21 Ningxia Academy of Agriculture and Forestry Sciences MONOBACTAM COMPOUNDS, THEIR PRODUCTION AND USE AS ANTIBACTERIAL AGENTS
EP4007759A4 (en) * 2020-08-06 2024-04-10 Ningxia Academy Agriculture & Forestry Sciences BETA-LACTAM COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIAL AGENTS
CN112079791A (zh) * 2020-08-21 2020-12-15 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺类抗生素侧链酸及其酯、其制备方法和应用
CN111909067B (zh) * 2020-08-28 2022-03-15 浙江凯普化工有限公司 一种d-青霉胺的有机全合成方法
WO2023082055A1 (zh) * 2021-11-09 2023-05-19 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途
US11932637B2 (en) 2021-11-18 2024-03-19 Merck Sharp & Dohme Llc Chromane amidine monobactam compounds for the treatment of bacterial infections

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794886A (fr) * 1972-02-22 1973-08-02 Pfizer Acides 6-(alpha-(omega-guanidinoalcanoylamino)acylamino)-penicillaniques
DE2458973A1 (de) * 1974-12-13 1976-06-16 Hoechst Ag Acylaminopenicillansaeuren und verfahren zu ihrer herstellung
DE2749265A1 (de) 1977-11-03 1979-05-10 Linde Ag Verfahren zur biologischen reinigung von abwasser
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
JPS58210061A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd １−スルホ−２−オキソアゼチジン誘導体、その製造法および用途
CA1262128A (en) 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
NZ205642A (en) 1982-10-06 1986-08-08 Squibb & Sons Inc Beta-lactams and pharmaceutical compositions
US4638060A (en) 1985-04-29 1987-01-20 E. R. Squibb & Sons, Inc. O-sulfated spiro β-lactam hydroxamic acids
EP0336667A3 (en) 1988-04-04 1991-04-10 E.R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
US5112968A (en) 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
CA2024282A1 (en) 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
ZA918014B (en) 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
WO2002022613A1 (en) * 2000-09-14 2002-03-21 Pantherix Limited 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
JP2007520484A (ja) 2004-01-27 2007-07-26 メルク フロスト カンパニー シクロオキシゲナーゼ−２インヒビターとしてのジアリール−２−（５ｈ）−フラノンの一酸化窒素放出プロドラッグ
AU2005339865B2 (en) 2005-09-23 2011-09-08 M's Science Corporation Piperidine and piperazine derivatives
CA2629570C (en) 2005-12-07 2012-11-27 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
CN102659683B (zh) 2006-02-14 2014-11-12 庵原化学工业株式会社 5-烷氧基-4-羟基甲基吡唑化合物的制备方法
US20090012054A1 (en) 2006-03-16 2009-01-08 Astellas Pharma Inc. Cephem Compounds and Use as Antimicrobial Agents
MX2009009918A (es) 2007-03-23 2009-10-19 Basilea Pharmaceutica Ag Medicamentos combinados para el tratamiento de infecciones bacterianas.
WO2009049028A1 (en) 2007-10-09 2009-04-16 Targegen Inc. Pyrrolopyrimidine compounds and their use as janus kinase modulators
SG171781A1 (en) * 2008-12-19 2011-07-28 Pfizer Monocarbams

Also Published As

Publication number Publication date
US20150045340A1 (en) 2015-02-12
PH12014501671B1 (en) 2014-11-10
CY1117955T1 (el) 2017-05-17
EP2806873A1 (en) 2014-12-03
RS55210B1 (sr) 2017-01-31
US9782390B2 (en) 2017-10-10
EA201400838A1 (ru) 2014-12-30
CA2862338A1 (en) 2013-08-01
ZA201405057B (en) 2017-09-27
TWI659953B (zh) 2019-05-21
MY173843A (en) 2020-02-24
LT2806873T (lt) 2016-10-10
BR112014017968A8 (pt) 2017-07-11
EA027126B1 (ru) 2017-06-30
PH12014501671A1 (en) 2014-11-10
ES2592403T3 (es) 2016-11-30
EP2806873B1 (en) 2016-06-15
CU20140090A7 (es) 2014-12-26
MX346602B (es) 2017-03-24
ME02532B (me) 2017-02-20
PL2806873T3 (pl) 2016-12-30
UY34585A (es) 2013-09-02
CO7101240A2 (es) 2014-10-31
ECSP14010249A (es) 2015-12-31
CN104203237A (zh) 2014-12-10
WO2013110643A1 (en) 2013-08-01
HK1203389A1 (zh) 2015-10-30
JP2015504907A (ja) 2015-02-16
SMT201600354B (it) 2016-11-10
AU2013211575B2 (en) 2017-03-02
US20170100379A1 (en) 2017-04-13
IN2014MN01640A (uk) 2015-05-22
JP5869701B2 (ja) 2016-02-24
CL2014001956A1 (es) 2014-11-07
NZ626951A (en) 2016-03-31
MX2014008915A (es) 2014-08-26
IL233805A0 (en) 2014-09-30
PT2806873T (pt) 2016-09-23
AP2014007880A0 (en) 2014-08-31
IL233805A (en) 2016-06-30
CU24273B1 (es) 2017-08-08
CA2862338C (en) 2019-04-16
AR089796A1 (es) 2014-09-17
TN2014000297A1 (en) 2015-12-21
KR102036393B1 (ko) 2019-10-24
SG11201403930XA (en) 2014-08-28
DK2806873T3 (en) 2016-08-29
MA35905B1 (fr) 2014-12-01
PE20142345A1 (es) 2015-01-09
AU2013211575A1 (en) 2014-07-24
SI2806873T1 (sl) 2016-10-28
US9556165B2 (en) 2017-01-31
KR20140114390A (ko) 2014-09-26
HUE030452T2 (en) 2017-05-29
BR112014017968A2 (uk) 2017-06-20
TW201343643A (zh) 2013-11-01
HRP20161171T1 (hr) 2016-11-04

Similar Documents

Publication Publication Date Title
UA110880C2 (uk) Заміщені амідином бета-лактами, їх одержання та застосування як антибактеріальних засобів
PH12016500676A1 (en) Pyrimidine fgfr4 inhibitors
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015010125A (es) Derivados de piridazinona-amidas.
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
PH12015501843A1 (en) Novel pyrazol derivatives
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
EA201591064A1 (ru) Новые производные пиридина
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
PH12015501073A1 (en) Novel pyridine derivatives
PH12015502118A1 (en) Pyridin-4-yl derivatives
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора
EA201600123A1 (ru) Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона
MX2015014470A (es) Analogos de combretastatina.
MX363458B (es) Nuevos derivados de tetrazolona.
MX2016005219A (es) Tinturas acidas, proceso para su produccion y su uso.
BR112015020611A2 (pt) compostos de carboxamida
UY34564A (es) Utilización en terapéutica de derivados de imidazopiridina
MX338113B (es) Proceso para la preparacion de polisulfonato de sodio del 5,14-dihidrotetraazapentaceno e intermediarios de los mismos.
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
UA75945U (uk) Діетиламід 2,7-дихлор-4-метилхінолін-6-сульфонової кислоти, який проявляє діуретичну активність
LV14779A (lv) 4-Amino-2-(1,2,3-triazol-1-il)-hinazolīna atvasinājumi un to sintēzes paņēmiens
UA79866U (uk) Застосування амідів 2-оксоіндолін-3-гліоксилової кислоти як засобів з антидепресивною дією
MX2016005222A (es) Tinturas acidas, proceso para su produccion y su uso.